HOME >> BIOLOGY >> NEWS
Jan. 23-26 conference in Oakland, Calif., to discuss aneuploid theory of cancer

Berkeley -- University of California, Berkeley, molecular biologist Peter Duesberg is hosting a four-day conference to examine evidence in support of the novel theory that abnormal numbers and structures of chromosomes, known as aneuploidy, cause cancer.

The invitation-only gathering of scientists and physicians is scheduled for Friday, Jan. 23, to Monday, Jan. 26, at the Waterfront Plaza Hotel in Oakland, Calif., located in Jack London Square.

Duesberg has challenged the assumption that underlies nearly all cancer research today -- that chance mutations in a handful of genes leads to the unchecked cell growth typical of cancer. The effects of changing the normal number of chromosomes, which contain thousands of genes, are far more dramatic than mutation of a few genes, Duesberg says.

In the past few decades, scientists have almost unanimously accepted a central dogma to explain cancer: that a mere four to seven gene mutations are necessary for a cell to turn into a cancer cell. Yet, many scientists find that this theory does not explain what they see in cancer cells, namely, gross changes in the number and arrangement of chromosomes. Duesberg, in a paper published in 2000, reviewed many of the inconsistencies dogging the mutation theory and presented evidence that duplicated or deformed chromosomes, a condition called aneuploidy, are responsible for cancer.

Other researchers argue that aneuploidy is one step or the first step, but not the only step, in cancer. Duesberg invited some 50 experts with a variety of viewpoints to present their research and debate the role of aneuploidy in cancer. Understanding the root cause of cancer is important, he says, because it affects everything from how cancer is diagnosed to what treatments might work.

Among the participants are:

  • Peter Duesberg, UC Berkeley professor of molecular and cell biology
  • Gert Auer, M.D. professor in the Institute of Oncology-Pathology, Karolinsk
    '"/>


Contact: Robert Sanders
rls@pa.urel.berkeley.edu
510-643-6998
University of California - Berkeley
20-Jan-2004


Page: 1 2

Related biology news :

1. Worlds largest scientific society convenes regional meeting September 23-26 in Savannah
2. IBD (Crohns/ulcerative colitis) conference adds 18 speakers; APS meeting starts Thursday
3. Rising childhood leukaemia incidence prompts conference
4. Society for conservation biology conference
5. The protection of human subjects in gene transfer research explored at conference in July
6. International research conferences at the Villa Vigoni
7. National nanotech expert to address UW-Madison conference
8. Landmark conference for United Nations on human cloning and stem cell research
9. European Society of Human Reproduction and Embryology conference - June 2004
10. First DFG research conference in the USA
11. UC San Diego to host two-day conference on sustainable development Dec. 11 & 12

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: